Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Pain and Therapy|September 28, 2021
Tapentadol Safety and Patient Characteristics Associated with Treatment Discontinuation in Cancer Therapy: A Retrospective Multicentre Study in JapanMichihiro Iwaki, Takaomi Kessoku, Taro Kanamori, et al.
Frontiers in Endocrinology|November 15, 2021
Endotoxins and Non-Alcoholic Fatty Liver DiseaseTakaomi Kessoku, Takashi Kobayashi, Kento Imajo, et al.
Hepatology (Baltimore, Md.)|December 24, 2021
Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver diseaseNobuyoshi Kawamura, Kento Imajo, Kyle J Kalutkiewicz, et al.
European Radiology|December 5, 2024
Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASHKento Imajo, Yusuke Saigusa, Takashi Kobayashi, et al.
Cancers|May 14, 2022
Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled TrialAnna Ozaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Contemporary Clinical Trials Communications|July 11, 2022
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipationAtsushi Yamamoto, Takaomi Kessoku, Kosuke Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 26, 2023
M-PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitisKento Imajo, Yusuke Saigusa, Takashi Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 16, 2022
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter studyYuya Seko, Hirokazu Takahashi, Hidenori Toyoda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 12, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLDYuya Seko, Taeang Arai, Hirokazu Takahashi, et al.
Pageof 9